This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitá Degli Studi Di Padova. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Giovanni Ribaudo: Innovator in Antitumoral Compounds
Introduction
Giovanni Ribaudo is a notable inventor based in Padua, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumoral agents. His work focuses on innovative compounds that have the potential to treat various forms of cancer.
Latest Patents
Ribaudo holds a patent for a 1-phenylpropanone compound, which is described as having the formula (I). This compound includes specific elements where X can be CH or an atom selected from the group consisting of O, S, and Se. The integer n ranges from 4 to 6, and A is a substituent chosen from a variety of options, including 4-morpholyl and 1-piperidinyl. This invention is particularly aimed at being used as an antitumoral agent in the treatment of breast cancer, chronic lymphatic leukemia, or neuroblastoma. The patent highlights the potential of these new compounds as effective antitumoral agents.
Career Highlights
Giovanni Ribaudo is affiliated with the Università degli Studi di Padova, where he conducts his research and development work. His academic background and ongoing research contribute to the advancement of cancer treatment methodologies. He has successfully secured a patent that underscores his innovative approach to medicinal chemistry.
Collaborations
Ribaudo collaborates with esteemed colleagues such as Anna Maria Brunati and Livio Trentin. Their combined expertise enhances the research efforts in developing new therapeutic agents.
Conclusion
Giovanni Ribaudo's work in the field of antitumoral compounds represents a significant advancement in cancer treatment. His innovative approach and collaboration with fellow researchers continue to pave the way for new therapeutic possibilities.